Suppr超能文献

乙型肝炎病毒感染可在不太严重的肝硬化中导致肝细胞癌:对来自印度北部142例患者的比较研究

Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India.

作者信息

Arora Anil, Sharma Praveen, Tyagi Pankaj, Singla Vikas, Arora Veronica, Bansal Naresh, Toshniwal Jay, Kumar Ashish

机构信息

Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi 110 060, India.

出版信息

J Clin Exp Hepatol. 2013 Dec;3(4):288-95. doi: 10.1016/j.jceh.2013.08.007. Epub 2013 Sep 20.

Abstract

BACKGROUND AND AIMS

The clinical profile of patients with hepatocellular carcinoma (HCC) may differ depending on the etiology of HCC. There is no study from India comparing the clinical profile of patients of HCC due to hepatitis B virus (HBV) infection with other etiologies.

METHODS

We retrospectively reviewed the records of patients clinically diagnosed as HCC between Nov 2000 and Dec 2012 admitted under a single unit of Department of Gastroenterology at our hospital. We compared the clinical presentation of patients of Hepatitis B virus etiology (HBV group) with other etiologies (Non-HBV group).

RESULTS

One hundred and forty-two patients were included (median age 60 years [range 30-83], 92% males). The etiology was HBV in 56 (39%) and among the non-HBV group (n = 86, 61%) the etiological spectrum was following: alcohol 31 (22%), cryptogenic 26 (18%), HCV 27 (19%), and miscellaneous 2 (1%). The median age of presentation was significantly less for HBV group than in non-HBV (56 [30-77] vs. 62 [42-83] years, P < 0.01). Clinical evidence of cirrhosis was significantly less common in the HBV group than non-HBV group (74% vs 98%, P < 0.01). HBV group had lower CTP score than non-HBV (median CTP score 7 vs 8,P < 0.05). Ascites was more common in non-HBV group than HBV group (65% vs 43%, P = 0.018). The BCLC staging was: A 13%, B 23%, C 35%, and D 29%, and there was no difference in tumor characteristics or BCLC staging between HBV or the non-HBV group.

CONCLUSIONS

HBV is a common cause of HCC in India, accounting for 39% of cases. The tumor characteristics of HCC due to HBV is similar to other etiologies, however, HBV causes HCC at an earlier age, and in less advanced or even absence of cirrhosis, thus further consolidating the directly carcinogenic potential of HBV.

摘要

背景与目的

肝细胞癌(HCC)患者的临床特征可能因HCC的病因不同而有所差异。印度尚无研究比较乙型肝炎病毒(HBV)感染所致HCC患者与其他病因所致HCC患者的临床特征。

方法

我们回顾性分析了2000年11月至2012年12月间我院胃肠病科单一病房收治的临床诊断为HCC患者的病历。我们比较了乙型肝炎病毒病因组(HBV组)与其他病因组(非HBV组)患者的临床表现。

结果

共纳入142例患者(中位年龄60岁[范围30 - 83岁],92%为男性)。病因是HBV的有56例(39%),在非HBV组(n = 86,61%)中,病因谱如下:酒精性31例(22%),隐源性26例(18%),丙型肝炎病毒(HCV)27例(19%),其他2例(1%)。HBV组的中位发病年龄显著低于非HBV组(56[30 - 77]岁对62[42 - 83]岁,P < 0.01)。HBV组肝硬化的临床证据显著少于非HBV组(74%对98%,P < 0.01)。HBV组的CTP评分低于非HBV组(中位CTP评分7对8,P < 0.05)。腹水在非HBV组比HBV组更常见(65%对43%,P = 0.018)。巴塞罗那临床肝癌(BCLC)分期为:A期13%,B期23%,C期35%,D期29%,HBV组与非HBV组之间的肿瘤特征或BCLC分期无差异。

结论

HBV是印度HCC的常见病因,占病例的39%。HBV所致HCC与其他病因所致HCC的肿瘤特征相似,然而,HBV导致HCC的发病年龄更早,且肝硬化程度较轻甚至无肝硬化,从而进一步证实了HBV的直接致癌潜力。

相似文献

引用本文的文献

7
Current Scenario of Hepatitis B and Its Treatment in India.印度乙型肝炎的现状及其治疗
J Clin Transl Hepatol. 2017 Sep 28;5(3):277-296. doi: 10.14218/JCTH.2017.00024. Epub 2017 Jul 8.

本文引用的文献

1
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
2
Hepatitis B virus infection and the risk of hepatocellular carcinoma.乙型肝炎病毒感染与肝细胞癌风险。
World J Gastroenterol. 2011 Nov 28;17(44):4853-7. doi: 10.3748/wjg.v17.i44.4853.
4
Hepatocellular carcinoma.肝细胞癌
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
10
Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.肝细胞癌:流行病学、监测和诊断。
Semin Liver Dis. 2010 Feb;30(1):3-16. doi: 10.1055/s-0030-1247128. Epub 2010 Feb 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验